Copyright Reports & Markets. All rights reserved.

Global Drug Safety and Pharmacovigilance Software Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Drug Safety and Pharmacovigilance Software Market Status and Forecast (2016-2027)
      • 1.3.2 Global Drug Safety and Pharmacovigilance Software Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Drug Safety and Pharmacovigilance Software Supply by Company

    • 2.1 Global Drug Safety and Pharmacovigilance Software Sales Value by Company
    • 2.2 Drug Safety and Pharmacovigilance Software Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Drug Safety and Pharmacovigilance Software Market Status by Type

    • 3.1 Drug Safety and Pharmacovigilance Software Type Introduction
      • 3.1.1 ADR Reporting
      • 3.1.2 Drug Safety Audits
      • 3.1.3 Issue Tracking
      • 3.1.4 Fully Integrated Software
    • 3.2 Global Drug Safety and Pharmacovigilance Software Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Drug Safety and Pharmacovigilance Software Market Status by Application

    • 4.1 Drug Safety and Pharmacovigilance Software Segment by Application
      • 4.1.1 Pharma & Biotech Companies
      • 4.1.2 CROs
      • 4.1.3 BPOs
      • 4.1.4 Others
    • 4.2 Global Drug Safety and Pharmacovigilance Software Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Drug Safety and Pharmacovigilance Software Market Status by Region

    • 5.1 Global Drug Safety and Pharmacovigilance Software Market by Region
    • 5.2 North America Drug Safety and Pharmacovigilance Software Market Status
    • 5.3 Europe Drug Safety and Pharmacovigilance Software Market Status
    • 5.4 Asia Pacific Drug Safety and Pharmacovigilance Software Market Status
    • 5.5 Central & South America Drug Safety and Pharmacovigilance Software Market Status
    • 5.6 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Status

    6 North America Drug Safety and Pharmacovigilance Software Market Status

    • 6.1 North America Drug Safety and Pharmacovigilance Software Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Drug Safety and Pharmacovigilance Software Market Status

    • 7.1 Europe Drug Safety and Pharmacovigilance Software Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Drug Safety and Pharmacovigilance Software Market Status

    • 8.1 Asia Pacific Drug Safety and Pharmacovigilance Software Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Drug Safety and Pharmacovigilance Software Market Status

    • 9.1 Central & South America Drug Safety and Pharmacovigilance Software Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Drug Safety and Pharmacovigilance Software Market Status

    • 10.1 Middle East & Africa Drug Safety and Pharmacovigilance Software Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Drug Safety and Pharmacovigilance Software Market Forecast by Type and by Application

    • 12.1 Global Drug Safety and Pharmacovigilance Software Sales Value Forecast (2022-2027)
    • 12.2 Global Drug Safety and Pharmacovigilance Software Forecast by Type
    • 12.3 Global Drug Safety and Pharmacovigilance Software Forecast by Application

    13 Global Drug Safety and Pharmacovigilance Software Market Forecast by Region/Country

    • 13.1 Global Drug Safety and Pharmacovigilance Software Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 United BioSource Corporation
      • 14.1.1 Company Information
      • 14.1.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.1.3 United BioSource Corporation Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sparta Systems, Inc.
      • 14.2.1 Company Information
      • 14.2.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.2.3 Sparta Systems, Inc. Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Sarjen Systems
      • 14.3.1 Company Information
      • 14.3.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.3.3 Sarjen Systems Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Oracle Corporation
      • 14.4.1 Company Information
      • 14.4.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.4.3 Oracle Corporation Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Online Business Applications Inc
      • 14.5.1 Company Information
      • 14.5.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.5.3 Online Business Applications Inc Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Max Application
      • 14.6.1 Company Information
      • 14.6.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.6.3 Max Application Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 EXTEDO GmbH
      • 14.7.1 Company Information
      • 14.7.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.7.3 EXTEDO GmbH Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Ennov Solutions Inc
      • 14.8.1 Company Information
      • 14.8.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.8.3 Ennov Solutions Inc Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 ArisGlobal
      • 14.9.1 Company Information
      • 14.9.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.9.3 ArisGlobal Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 AB cube
      • 14.10.1 Company Information
      • 14.10.2 Drug Safety and Pharmacovigilance Software Product Introduction
      • 14.10.3 AB cube Drug Safety and Pharmacovigilance Software Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Drug Safety and Pharmacovigilance Software market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Drug Safety and Pharmacovigilance Software industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Drug Safety and Pharmacovigilance Software market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Drug Safety and Pharmacovigilance Software Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Drug Safety and Pharmacovigilance Software market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Drug Safety and Pharmacovigilance Software Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Drug Safety and Pharmacovigilance Software industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      ADR Reporting
      Drug Safety Audits
      Issue Tracking
      Fully Integrated Software

      Segmented by Application
      Pharma & Biotech Companies
      CROs
      BPOs
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      United BioSource Corporation
      Sparta Systems, Inc.
      Sarjen Systems
      Oracle Corporation
      Online Business Applications Inc
      Max Application
      EXTEDO GmbH
      Ennov Solutions Inc
      ArisGlobal
      AB cube
      Buy now